(in Canadian dollars except as otherwise noted)
TORONTO, May 10, 2022
/CNW/ - (TSX: IFC)
Highlights
- Net operating income per share increased 13% to $2.70, driven by accretion from RSA and
growth in distribution income
- Operating DPW1 grew 86% in the quarter driven
by the RSA acquisition and 8% organic growth, led by commercial
lines
- Operating combined ratio was a solid 91.7%, but 2.4
points higher than last year due to elevated catastrophe
losses
- EPS of $2.53 in the
quarter reflected solid operating results but declined from the
prior-year period, which included a large investment gain
- OROE of 16.6% and ROE of 14.9%, with BVPS growth of 32%
and $2.6 billion total capital
margin
- RSA integration progressing well and delivered 12%
accretion to NOIPS in the quarter
Charles Brindamour, Chief Executive Officer, said:
"We continued to deliver solid results in Q1-2022 and made
significant headway in integrating RSA. Our people are
collaborating well together, sharing expertise and working to
ensure a seamless transition for customers. We have also taken
actions to optimize our UK&I footprint and focus our efforts to
drive outperformance. Subsequent to quarter end, we announced the
sale of RSA's Middle East business
and closed the sale of Codan Denmark. Our robust balance sheet,
strong book of business and industry leading talent put us on
strong footing to support our customers through this volatile time
and capture opportunities as they arise."
Consolidated
Highlights1
|
(in millions of
Canadian dollars except as otherwise noted)
|
Q1-2022
|
Q1-2021
|
Change
|
Operating direct
premiums written1
|
4,678
|
2,522
|
86%
|
Direct premiums
written
|
5,093
|
2,543
|
100%
|
Operating combined
ratio1
|
91.7%
|
89.3%
|
2.4 pts
|
Underwriting
income1
|
396
|
297
|
33%
|
Operating net
investment income1
|
205
|
141
|
45%
|
Distribution
income1
|
92
|
62
|
48%
|
Net operating income
attributable to common shareholders1
|
475
|
344
|
38%
|
Net income
|
447
|
514
|
(13)%
|
Per share measures (in
dollars)
|
|
|
|
Net
operating income per share (NOIPS)1
|
$2.70
|
$2.40
|
13%
|
Earnings
per share (EPS)
|
$2.53
|
$3.51
|
(28)%
|
Return on equity for
the last 12 months
|
|
|
|
Operating
ROE1
|
16.6%
|
19.0%
|
(2.4) pts
|
ROE
|
14.9%
|
17.6%
|
(2.7) pts
|
Book value per share
(in dollars)1
|
82.20
|
62.19
|
32%
|
Total capital
margin
|
2,567
|
3,008
|
(441)
|
Adjusted
debt-to-total-capital ratio1
|
23.9%
|
22.5%
|
1.4 pts
|
Common Share Dividend
- The Board of Directors approved the quarterly dividend to
$1.00 per share on the Company's
outstanding common shares. The dividends are payable on
June 30, 2022, to shareholders of
record on June 15, 2022.
Normal Course Issuer Bid
- As at March 31, 2022, the Company
had repurchased and cancelled 91,400 common shares for
approximately $16.7 million under its
normal course issuer bid ("NCIB"). The NCIB allows for the
purchase, for cancellation, of up to 5,282,458 common shares until
February 15, 2023, representing
approximately 3% of the Company's issued and outstanding common
shares as at February 8, 2022.
___________________________
|
1 This
press release contains non-GAAP financial measures. Refer to
Section 23 – Non-GAAP and other financial measures in the
Q1-2021 Management's Discussion and Analysis for further details.
DPW change (growth) is presented in constant
currency.
|
12-Month Industry Outlook
- Canadian industry profitability was strong in 2021, helped in
part by largely hard market conditions and favourable prior year
claims development. Over the next twelve months, we expect
firm-to-hard insurance market conditions to continue, supported by
high pre-pandemic combined ratios, inflation, climate change and
the still relatively low interest rate environment.
- In Canada personal lines, we
expect firm market conditions to continue in property and expect
auto to return to low-to-mid single-digit growth as driving
patterns return to pre-pandemic norms.
- In commercial lines in both US and Canada, hard market conditions are expected to
continue.
- In the UK&I, hard market conditions are expected to
continue across commercial lines. In personal lines, near term
industry growth remains uncertain as companies navigate the
recently introduced pricing reforms.
Segment Results
(in millions of
Canadian dollars except as otherwise noted)
|
Q1-2022
|
Q1-2021
|
Change
|
Operating direct
premiums written
|
Canada
|
2,909
|
2,125
|
37%
|
UK&I
|
1,299
|
n/a
|
n/a
|
US
|
470
|
397
|
19%
|
Total
|
4,678
|
2,522
|
86%
|
Operating combined
ratio
|
Canada
|
90.1%
|
88.2%
|
1.9 pts
|
UK&I
|
98.9%
|
n/a
|
n/a
|
US
|
86.8%
|
96.3%
|
(9.5) pts
|
Total
|
91.7%
|
89.3%
|
2.4 pts
|
Underwriting
income
|
Canada
|
321
|
282
|
39
|
UK&I
|
12
|
n/a
|
n/a
|
US
|
55
|
14
|
41
|
Corporate and
Other
|
8
|
1
|
7
|
Total
|
396
|
297
|
99
|
Q1-2022 Insurance Business Performance
- Operating DPW growth of 86% in constant currency mainly
reflected the RSA acquisition. Organic growth was strong at 8%, led
by 15% growth in commercial lines.
- Operating combined ratio of 91.7% was solid and included
$182 million (3.8 points) of
catastrophe losses, which exceeded expectations. The operating
combined ratio in Canada was a
strong 90.1%, reflecting solid underlying performance and
favourable prior year claims development. In the UK&I, the
operating combined ratio was 98.9% and included 10.4 points of
catastrophe losses. In the US, the operating combined ratio
improved to a very strong 86.8%.
Lines of Business
P&C Canada
- Personal auto premiums grew by 37%, driven mainly by
RSA. The operating combined ratio was a healthy 93.0% as the impact
of winter weather conditions was offset by higher favourable prior
year claims development and lower expenses. Driving activity was up
from the prior year but remained below pre-pandemic levels.
- Personal property premiums grew by 38%, mainly driven by
RSA and 5 points of organic growth due to firm market conditions.
The operating combined ratio remained strong at 87.6%, but was 10.2
points higher than last year, reflecting 6.1 points of higher
catastrophe losses.
- Commercial lines premium growth of 36% was mainly driven
by RSA. Organic growth was strong at 13%, reflecting hard market
conditions. The operating combined ratio improved by 1.6 points to
88.5%, reflecting solid underlying performance and elevated
favourable prior year claims development.
- Distribution income grew by 48% compared to a strong
prior-year quarter, driven by higher variable commissions and
accretive acquisitions over the past 12 months.
P&C UK&I
- Personal lines operating DPW was $479 million. We remained disciplined in
competitive market conditions, with recent pricing reforms
impacting UK home and motor. UK pet continues to perform well,
driven by new business. The operating combined ratio of 110.4%
included 13.8 points of catastrophe losses.
- Commercial lines operating DPW was $820 million in hard market conditions. The
operating combined ratio was a strong 90.0%, driven by solid
underlying performance and strong favourable prior year claims
development, partially offset by 7.8 points of catastrophe
losses.
P&C US
- US Commercial premium growth was strong at 19% on a
constant currency basis, driven by new business, increasing
exposures, and rate increases in favourable market conditions.
The operating combined ratio of 86.8% improved by 9.5
points from the prior year, reflecting strong underlying
performance and our exit from Public Entities during the
quarter.
Investments
- Operating net investment income of $205 million for the quarter increased 45%
year-over-year, mainly driven by the RSA acquisition. During the
quarter, we also increased the turnover pace of the portfolio to
capture rising yields.
- Net gains excluding FVTPL bonds of $116 million primarily reflected realized gains
on equity securities and fair value gains on investment
properties.
Net Operating Income, EPS and ROE
- Net operating income attributable to common shareholders
of $475 million is up 38% from a year
ago, reflecting the contribution of RSA, as well as strong growth
in distribution income.
- Earnings per share of $2.53 in Q1-2022 were driven by solid operating
results, partially offset by integration expenses. This result is
lower than EPS of $3.51 in Q1-2021,
which included a large gain on a venture investment.
- Operating ROE of 16.6% and ROE of 14.9% for the
12 months to March 31, 2022 reflected
strong performance across the business.
Balance Sheet
- The Company ended the quarter in a strong financial position,
with a total capital margin of $2.6
billion. This represents a $0.3
billion reduction from Q4-2021, driven by the redemption of
Restricted Tier 1 notes in the UK and market movements.
- IFC's book value per share (BVPS) of $82.20 as at March 31,
2022 increased 32% from a year ago, driven by strong
earnings and the RSA financing.
- The adjusted debt-to-total capital ratio increased to
23.9% as at March 31,
2022, driven by the redemption of Restricted Tier 1 notes in
the quarter. Proceeds from the sale of Codan Denmark are being used
to pay down debt subsequent to quarter-end and bring the adjusted
debt-to-total-capital ratio in line with our 20% target.
RSA Acquisition
- RSA contributed approximately 12% to NOIPS for the
ten-month period since closing. Given the overall strength of
Intact's results, double-digit accretion is evidence of the quality
of the acquired businesses.
- We remain on track to realize at least $250 million of pre-tax annual run-rate synergies
in 2024. As at March 31, 2022 we
have delivered $125 million in
run-rate synergies.
- Integration activities are progressing as planned. In
Canada, policy conversion in the
broker channel is well underway. Over 50% of Personal Lines broker
policies and Commercial Lines small business and fleet policies
have converted to Intact systems to date.
- On May 2, 2022, we completed the
sale of our 50% stake in Codan Forsikring A/S's P&C business to
Alm. brand A/S Group for total proceeds of DKK 6.3 billion (~$1.15
billion).
- On April 4, 2022, we announced
the sale of our 50% stake in RSA Middle East to National Life &
General Insurance Company (NLGIC), majority owned by Oman
International Development and Investment Co. (OMINVEST).
Preferred Share Dividends
- The Board of Directors also approved a quarterly dividend of
21.225 cents per share on the
Company's Class A Series 1 preferred shares, 21.60625 cents per share on the Class A Series 3
preferred shares, 32.5 cents per
share on the Class A Series 5 preferred shares, 33.125 cents per share on the Class A Series 6
preferred shares, 30.625 cents per
share on the Class A Series 7 preferred shares, 33.75 cents per share on the Class A Series 9
preferred shares, and 38.48 cents per
share on the Class A Series 11 preferred shares. The dividends are
payable on June 30, 2022, to
shareholders of record on June 15,
2022.
Analysts' Estimates
- The average estimate of earnings per share and net
operating income per share for the quarter among the analysts
who follow the Company was $2.00 and
$2.38, respectively.
Management's Discussion and Analysis (MD&A) and
Consolidated Financial Statements
This Press Release, which was approved by the Company's Board of
Directors on the Audit Committee's recommendation, should be read
in conjunction with the Q1-2022 MD&A as well as the Q1-2022
Consolidated Financial Statements, which are available on the
Company's website at www.intactfc.com and later today on SEDAR at
www.sedar.com.
For the definitions of measures and other insurance-related
terms used in this Press Release, please refer to the MD&A and
to the glossary available in the "Investors" section of the
Company's website at www.intactfc.com.
Conference Call Details
Intact Financial Corporation will host a conference call to
review its earnings results tomorrow at 11:00 a.m. ET. To listen to the call via live
audio webcast and to view the Company's Financial Statements,
MD&A, presentation slides, Supplementary financial information
and other information not included in this press release, visit the
Company's website at www.intactfc.com and link to "Investors". The
conference call is also available by dialing 416-764-8659 or
1-888-664-6392 (toll-free in North
America). Please call 10 minutes before the start of the
call. A replay of the call will be available on May 10, 2022 at 2:00 p.m.
ET until midnight on May 18,
2022. To listen to the replay, call 416-764-8677 or
1-888-390-0541 (toll-free in North
America), entry code 026467. A transcript of the call will
also be made available on Intact Financial Corporation's
website.
About Intact Financial Corporation
Intact Financial Corporation (TSX: IFC) is the largest provider
of property and casualty (P&C) insurance in Canada, a leading provider of global specialty
insurance, and, with RSA, a leader in the U.K. and Ireland. Our business has grown organically
and through acquisitions to over $20
billion of total annual premiums.
In Canada, Intact distributes
insurance under the Intact Insurance brand through a wide network
of brokers, including its wholly-owned subsidiary BrokerLink, and
directly to consumers through belairdirect. Intact also provides
affinity insurance solutions through the Johnson Affinity
Groups.
In the US, Intact Insurance Specialty Solutions provides a range
of specialty insurance products and services through independent
agencies, regional and national brokers, and wholesalers and
managing general agencies.
Outside of North America, the
Company provides personal, commercial and specialty insurance
solutions across the U.K., Ireland, and Europe through the RSA brands.
Non-GAAP and other financial measures
Non-GAAP financial measures and Non-GAAP ratios (which are
calculated using non-GAAP financial measures) do not have
standardized meanings prescribed by IFRS (or GAAP) and may not be
comparable to similar measures used by other companies in our
industry. Non-GAAP and other financial measures are used by
management and financial analysts to assess our performance.
Further, they provide users with an enhanced understanding of our
financial results and related trends, and increase transparency and
clarity into the core results of the business.
Non-GAAP financial measures and Non-GAAP ratios used in this
Press Release and other Company's financial reports include
measures related to our consolidated performance, our underwriting
performance and our financial strength.
For more information about these supplementary financial
measures, non-GAAP financial measures, and non-GAAP ratios,
including definitions and explanations of how these measures
provide useful information, refer to Section 23 – Non-GAAP and
other financial measures in the Q1-2022 MD&A dated May 10, 2022, which is available on our website
at www.intactfc.com and on SEDAR at www.sedar.com.
Table 1 Reconciliation of NOI, NOIPS
and OROE to Net income attributable to shareholders, as reported
under IFRS
|
Q1-2022
|
Q1-2021
|
|
|
|
Net income
attributable to shareholders, as reported under IFRS
|
459
|
514
|
Remove:
Pre-tax non-operating losses
(gains)
|
-
|
(172)
|
Remove:
Non-operating tax expense
(benefit)1
|
47
|
15
|
Remove: Non-operating
component of NCI
|
(18)
|
-
|
NOI
|
488
|
357
|
Remove: preferred share
dividends
|
(13)
|
(13)
|
NOI attributable to
common shareholders
|
475
|
344
|
Divided by
weighted-average number of common shares (in millions)
|
176.1
|
143.0
|
NOIPS, basic and
diluted (in dollars)
|
2.70
|
2.40
|
NOI to common
shareholders for the last 12 months
|
2,148
|
1,532
|
Adjusted
average common shareholders' equity,
excluding AOCI
|
12,966
|
8,058
|
OROE for the last 12
months
|
16.6%
|
19.0%
|
Table 2 Reconciliation of Operating
DPW to DPW
|
Q1-2022
|
Q1-2021
|
|
|
|
DPW, as reported under
IFRS
|
5,093
|
2,543
|
Remove:
impact of industry pools and
fronting
|
(285)
|
(19)
|
Remove: DPW from exited
lines
|
(141)
|
(2)
|
Add: impact of the
normalization for multi-year policies
|
11
|
-
|
|
|
|
Operating DPW, as
reported in the MD&A
|
4,678
|
2,522
|
Operating DPW
growth
|
86%
|
-%
|
Operating DPW growth
(in constant currency)
|
86%
|
1%
|
Table 3 Reconciliation of
Underwriting income to Underwriting income as reported under
IFRS
|
Q1-2022
|
Q1-2021
|
|
|
|
Net earned premiums, as
reported under IFRS
|
4,891
|
2,777
|
Other underwriting
revenues, as reported under IFRS
|
73
|
35
|
Net claims incurred, as
reported under IFRS
|
(2,547)
|
(1,431)
|
Underwriting expenses,
as reported under IFRS
|
(1,597)
|
(956)
|
Underwriting income
(loss), as calculated under IFRS
|
820
|
425
|
Remove: impact of MYA
on underwriting results
|
(466)
|
(146)
|
Remove: non-operating
pension expense
|
13
|
16
|
Remove: underwriting
loss (income) from exited lines
|
29
|
2
|
Underwriting income
(loss), as reported in the MD&A
|
396
|
297
|
Operating
NEP
|
4,742
|
2,759
|
|
|
|
Operating combined
ratio
|
91.7%
|
89.3%
|
Table 4 Reconciliation of Operating
net claims to Net claims incurred, as reported under IFRS
|
|
Q1-2022
|
Q1-2021
|
|
|
|
Net claims incurred,
as reported under IFRS
|
2,547
|
1,431
|
Remove: positive
(negative) impact of MYA on underwriting results
|
466
|
146
|
Remove: adjustment for
non-operating pension expense
|
(5)
|
(6)
|
Remove: net claims from
exited lines
|
(115)
|
(14)
|
Net with: other
underwriting revenues
|
(10)
|
-
|
|
|
|
Operating net
claims, as reported in the MD&A
|
2,883
|
1,557
|
Remove: net current
year CAT losses
|
(182)
|
(52)
|
Remove: favourable
(unfavourable) PYD
|
223
|
150
|
|
|
|
Operating net claims
excluding current year CAT losses and PYD
|
2,924
|
1,655
|
Operating
NEP
|
4,742
|
2,759
|
Remove: reinstatement
premiums ceded (recovered)
|
-
|
-
|
Operating
NEP before reinstatement premiums
|
4,742
|
2,759
|
|
|
|
Underlying current year
loss ratio1
|
61.7%
|
60.0%
|
CAT loss ratio
(including reinstatement premiums) 1
|
3.8%
|
1.9%
|
(Favourable)
unfavourable PYD ratio2
|
(4.7)%
|
(5.4)%
|
Claims
ratio2
|
60.8%
|
56.5%
|
|
|
|
|
1 Calculated using Operating NEP
before reinstatement premiums.
|
2 Calculated
using Operating NEP.
|
Table 5 Reconciliation of Operating
net underwriting expenses to Underwriting expenses as reported
under IFRS
|
Q1-2022
|
Q1-2021
|
|
|
|
Underwriting
expenses, as reported under IFRS
|
1,597
|
956
|
Net with: other
underwriting revenues
|
(63)
|
(35)
|
Remove: adjustment for
non-operating pension expense
|
(8)
|
(10)
|
Remove: underwriting
expenses from exited lines
|
(63)
|
(6)
|
Operating net
underwriting expenses, as reported in the MD&A
|
1,463
|
905
|
Commissions
|
741
|
482
|
General
expenses
|
589
|
325
|
Premium
taxes
|
133
|
98
|
Operating
NEP
|
4,742
|
2,759
|
Commissions
ratio
|
15.7%
|
17.5%
|
General expenses
ratio
|
12.4%
|
11.8%
|
Premium taxes
ratio
|
2.8%
|
3.5%
|
Expense
ratio
|
30.9%
|
32.8%
|
|
|
|
|
Table 6 Reconciliation of ROE to Net income
attributable to shareholders, as reported under IFRS
|
|
Q1-2022
|
Q1-2021
|
|
|
|
Net income
attributable to shareholders
|
459
|
514
|
Remove: preferred share
dividends
|
(13)
|
(13)
|
|
|
|
Net income
attributable to common shareholders
|
446
|
501
|
Divided by
weighted-average number of common shares (in millions)
|
176.1
|
143.0
|
EPS, basic and
diluted (in dollars)
|
2.53
|
3.51
|
|
|
|
Net income
attributable to common shareholders for the last 12
months
|
1,959
|
1,436
|
Adjusted
average common shareholders'
equity
|
13,115
|
8,145
|
ROE for the last 12
months
|
14.9%
|
17.6%
|
|
|
|
|
|
Table 7 Reconciliation of Distribution
income, Total finance costs, Other operating income (expense),
Total income taxes and Underwriting income with the Consolidated
financial statements
|
MD&A
captions
|
Pre-tax
|
|
|
As presented in the
Financial statements
|
Distribution
income
|
Total
finance
costs
|
Other
operating
income
(expense)1
|
Operating investment
income
|
Total
income
taxes
|
Non-
operating
losses
|
Underwriting
income
|
Total F/S
caption
|
For the quarter
ended March 31, 2022
|
|
|
|
|
|
|
|
|
Underwriting income1
|
-
|
-
|
-
|
-
|
-
|
424
|
396
|
820
|
Investment income
|
-
|
|
|
213
|
|
2
|
|
215
|
Other revenues
|
131
|
-
|
3
|
-
|
-
|
-
|
-
|
134
|
Net
gains (losses)
|
-
|
-
|
-
|
-
|
-
|
(296)
|
-
|
(296)
|
Share of profits from invest. in ass. & JV
|
38
|
(1)
|
-
|
-
|
(8)
|
(4)
|
-
|
25
|
Finance costs
|
-
|
(41)
|
-
|
-
|
-
|
-
|
-
|
(41)
|
Acquisition, integration and restructuring costs
|
-
|
-
|
-
|
-
|
-
|
(64)
|
-
|
(64)
|
Other expenses
|
(77)
|
-
|
(34)
|
-
|
-
|
(62)
|
-
|
(173)
|
Income tax benefit (expense)
|
-
|
-
|
-
|
-
|
(165)
|
-
|
-
|
(165)
|
|
|
|
|
|
|
|
|
|
Total, as reported
in MD&A
|
92
|
(42)
|
(31)
|
213
|
(173)
|
-
|
396
|
|
For the quarter
ended March 31, 2021
|
|
|
|
|
|
|
|
|
Underwriting income1
|
-
|
-
|
-
|
-
|
-
|
128
|
297
|
425
|
Other revenues
|
89
|
-
|
3
|
-
|
-
|
-
|
-
|
92
|
Net
gains (losses)
|
-
|
-
|
-
|
-
|
-
|
118
|
-
|
118
|
Share of profits from invest. in ass. & JV
|
23
|
(4)
|
-
|
-
|
(4)
|
(4)
|
-
|
11
|
Finance costs
|
-
|
(28)
|
-
|
-
|
-
|
-
|
-
|
(28)
|
Acquisition, integration and restructuring costs
|
-
|
-
|
-
|
-
|
-
|
(43)
|
-
|
(43)
|
Other expenses
|
(50)
|
-
|
(9)
|
-
|
-
|
(27)
|
-
|
(86)
|
Income tax benefit (expense)
|
-
|
-
|
-
|
-
|
(116)
|
-
|
-
|
(116)
|
|
|
|
|
|
|
|
|
|
Total, as reported
in MD&A
|
62
|
(32)
|
(6)
|
-
|
(120)
|
172
|
297
|
|
|
|
|
|
|
|
|
|
|
|
1 Comprised of the following captions
in the Consolidated statements of income: Net earned premiums,
Other underwriting revenues, Net claims incurred and Underwriting
expenses.
|
Table 8 Calculation of BVPS and BVPS
(excluding AOCI)
As at March
31,
|
|
|
2022
|
2021
|
|
|
|
|
|
Equity attributable to
shareholders, as reported under
IFRS
|
|
|
15,787
|
10,069
|
Remove:
Preferred shares, as reported under IFRS
|
|
|
(1,322)
|
(1,175)
|
|
|
|
|
|
Common shareholders'
equity
|
|
|
14,465
|
8,894
|
Remove:
AOCI, as
reported under IFRS
|
|
|
69
|
(365)
|
|
|
|
|
|
Common shareholders'
equity (excluding AOCI)
|
|
|
14,534
|
8,529
|
|
|
|
|
|
Number of common shares
outstanding at the same date (in
millions)
|
|
|
175.991
|
143.018
|
BVPS
|
|
|
82.20
|
62.19
|
BVPS (excluding
AOCI)
|
|
|
82.58
|
59.64
|
|
|
|
|
|
|
Table 9 Adjusted average common
shareholders' equity and Adjusted average common shareholders'
equity (excluding AOCI)
As at March
31,
|
2022
|
2021
|
|
|
|
|
Ending common
shareholders' equity
|
14,465
|
8,894
|
|
|
Remove:
common shares issued during the period
|
(4,311)
|
-
|
|
|
Ending common
shareholders' equity, excluding common shares issued during the
period
|
10,154
|
8,894
|
|
|
Beginning common
shareholders' equity
|
8,894
|
7,396
|
|
|
Average common
shareholders' equity, excluding common shares issued during the
period
|
9,524
|
8,145
|
|
|
Weighted impact of June
1, 2021 common shares issuance
|
3,591
|
-
|
|
|
Adjusted average common shareholders'
equity
|
13,115
|
8,145
|
|
|
|
|
|
Ending
common shareholders' equity
(excluding AOCI)
|
14,534
|
8,529
|
|
|
Remove:
common shares issued during the period
|
(4,311)
|
-
|
|
|
Ending common
shareholders' equity, excluding AOCI and common shares issued
during the period
|
10,223
|
8,529
|
|
|
Beginning common
shareholders' equity, excluding AOCI
|
8,529
|
7,586
|
|
|
Average common
shareholders' equity, excluding AOCI and common shares issued during the
period
|
9,375
|
8,058
|
|
|
Weighted impact of June
1, 2021 common shares issuance
|
3,591
|
-
|
|
|
Adjusted average common shareholders'
equity, excluding AOCI
|
12,966
|
8,058
|
|
|
|
|
|
|
Table 10 Reconciliation of Debt outstanding
(excluding hybrid debt) and Adjusted total capital to Debt
outstanding, Equity attributable to shareholders and Equity
attributable to NCI, as reported under IFRS
As at
|
March
31
2022
|
Dec.
31
2021
|
|
|
|
Debt outstanding, as
reported under IFRS
|
5,370
|
5,229
|
Remove: hybrid
subordinated notes
|
(247)
|
(247)
|
|
|
|
Debt outstanding
(excluding hybrid debt)
|
5,123
|
4,982
|
|
|
|
Debt outstanding, as
reported under IFRS
|
5,370
|
5,229
|
Equity attributable to
shareholders, as reported under IFRS
|
15,787
|
15,674
|
Equity attributable to
NCI, as reported under IFRS
|
|
|
Include:
RSA Insurance Group plc, as reported under IFRS
Tier 1 notes
|
-
|
510
|
Preferred shares
|
285
|
285
|
Adjusted total
capital
|
21,442
|
21,698
|
|
|
|
Debt outstanding
(excluding hybrid debt)
|
5,123
|
4,982
|
Adjusted total
capital
|
21,442
|
21,698
|
Adjusted
debt-to-total capital ratio
|
23.9%
|
23.0%
|
|
|
|
Debt outstanding, as
reported under IFRS
|
5,370
|
5,229
|
Preferred shares, as
reported under IFRS
|
1,322
|
1,175
|
Equity attributable to
NCI: RSA Insurance Group plc,
as reported under IFRS
Tier 1 notes
|
-
|
510
|
Preferred shares
|
285
|
285
|
Debt outstanding and
preferred shares (including NCI)
|
6,977
|
7,199
|
Adjusted total
capital (see above)
|
21,442
|
21,698
|
Total leverage
ratio
|
32.5%
|
33.2%
|
Adjusted debt-to-total
capital ratio
|
23.9%
|
23.0%
|
Preferred shares and hybrids
|
8.6%
|
10.2%
|
Forward Looking Statements
Certain statements made in this news release are forward-looking
statements. These statements include, without limitation,
statements relating to the outlook for the property and casualty
insurance industry in Canada, the
US and the UK, the Company's business outlook, the Company's growth
prospects, the impact on the Company of the occurrence of and
response to the coronavirus (COVID-19) pandemic and ensuing events,
the acquisition and integration of RSA, the sale of the Company's
50% stake in RSA Middle East B.S.C. (c) to National Life &
General Insurance Company (NLGIC), the receipt of all requisite
approvals or clearances of the Sale of Middle East in a timely
manner and on terms acceptable to the Company, the realization of
the expected strategic, financial and other benefits of the Sale of
Middle East, and the sale of Codan Forsikring A/S's Danish business
(the "Sale"). All such forward-looking statements are made pursuant
to the 'safe harbour' provisions of applicable Canadian securities
laws.
Forward-looking statements, by their very nature, are subject to
inherent risks and uncertainties and are based on several
assumptions, both general and specific, which give rise to the
possibility that actual results or events could differ materially
from our expectations expressed in or implied by such
forward-looking statements as a result of various factors,
including those discussed in the Company's most recently filed
Annual Information Form dated February 8,
2022 and available on SEDAR at www.sedar.com. As a result,
we cannot guarantee that any forward-looking statement will
materialize and we caution you against relying on any of these
forward-looking statements. Except as may be required by Canadian
securities laws, we do not undertake any obligation to update or
revise any forward-looking statements contained in this news
release, whether as a result of new information, future events or
otherwise. Please read the cautionary note at the beginning of the
Q1-2022 MD&A.
SOURCE Intact Financial Corporation